99 related articles for article (PubMed ID: 24809208)
1. Population pharmacokinetics of cefditoren pivoxil in non-infected adults.
Matsumoto K; Sato N; Mitomi N; Shitara Y; Shibasaki S
Jpn J Antibiot; 2014 Feb; 67(1):49-66. PubMed ID: 24809208
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetic analysis of cefditoren pivoxil in pediatric patients with infection.
Matsumoto K; Sato N; Mitomi N; Shibasaki S
Jpn J Antibiot; 2013 Dec; 66(6):357-75. PubMed ID: 24649799
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacokinetic, bacteriological and clinical evaluation of cefditoren pivoxil in pediatrics].
Iwai N; Nakamura H; Miyazu M; Watanabe Y
Jpn J Antibiot; 1994 Feb; 47(2):181-94. PubMed ID: 8151911
[TBL] [Abstract][Full Text] [Related]
4. [Basic and clinical studies on cefditoren pivoxil in pediatric field].
Motohiro T; Handa S; Yamada S; Oki S; Yoshinaga Y; Sasaki H; Aramaki M; Oda K; Sakata Y; Kato H
Jpn J Antibiot; 1994 Apr; 47(4):409-27. PubMed ID: 8201769
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the safety and efficacy of cefditoren pivoxil fine granules for pediatric use in pediatric patients with acute otitis media].
Kawamata S; Yamada H; Sato Y; Sasagawa Y; Iwama Y; Matumoto M
Jpn J Antibiot; 2010 Jun; 63(3):207-23. PubMed ID: 20976878
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetic, bacteriological and clinical studies on cefditoren pivoxil in children].
Tajima T; Kobayashi M; Negishi S; Nishimura S; Yoshida A; Kudo S; Gondou M; Nakayama T; Abe T
Jpn J Antibiot; 1993 Jul; 46(7):589-95. PubMed ID: 8371494
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of cefditoren pivoxil in the treatment of acute otitis media due to benzylpenicillin-insensitive Streptococcus pneumoniae].
Sugita R; Deguchi K; Kimura S; Harada S; Fujimaki Y; Watanabe H; Naito M; Nomura T; Tanaka M; Komatsu N; Shimizu K; Yoshida Y; Okano K
Jpn J Antibiot; 1996 Apr; 49(4):386-98. PubMed ID: 8786629
[TBL] [Abstract][Full Text] [Related]
8. Prediction of clinical bacteriological efficacy of oral antibiotics using a mechanism-based pharmacokinetic-pharmacodynamics modeling.
Matsumoto K; Sugano T; Sato N; Ida T; Shibasaki S
Jpn J Antibiot; 2014 Feb; 67(1):33-47. PubMed ID: 24809207
[TBL] [Abstract][Full Text] [Related]
9. [Bacteriological, pharmacokinetic and clinical studies of cefditoren pivoxil in the pediatric field].
Toyonaga Y; Ishihara T; Sano T; Tezuka T; Nakamura H
Jpn J Antibiot; 1993 Jul; 46(7):604-28. PubMed ID: 8371496
[TBL] [Abstract][Full Text] [Related]
10. [Causative organisms of acute otitis media and acute sinusitis in children and their susceptibility of oral beta-lactam antibiotics].
Takenaka M; Morikawa Y; Nakagawa T; Takashima T; Haruta T; Tsuji T
Jpn J Antibiot; 1999 Feb; 52(2):162-71. PubMed ID: 10221181
[TBL] [Abstract][Full Text] [Related]
11. [Antibacterial activity of oral cephems against various clinically isolated strains and evaluation of efficacy based on the pharmacokinetics/pharmacodynamics theory].
Nakamura T; Takahashi H
Jpn J Antibiot; 2004 Dec; 57(6):465-74. PubMed ID: 15747584
[TBL] [Abstract][Full Text] [Related]
12. [Clinical long-term studies of the treatment of chronic complicated urinary tract infections. Utility and recurrence after 14-day treatment by cefditoren pivoxil].
Arakawa S; Takagi S; Kamidono S; Kataoka N; Tomioka O; Hazama M; Hirose T; Yamazaki K; Kumamoto Y; Hayashi K
Jpn J Antibiot; 1993 Jan; 46(1):75-94. PubMed ID: 8455334
[TBL] [Abstract][Full Text] [Related]
13. [Antibiotic therapy against acute tonsillopharyngitis in children due to group A beta-hemolytic streptococci: comparison of clinical efficacy, the bactericidal effects, and effects on oral flora between cefditoren pivoxil for 5 days and amoxicillin for 10 days].
Tsumura N; Nagai K; Hidaka H; Otsu Y; Tanaka Y; Ikezawa S; Honma S; Shindo S; Ubukata K
Jpn J Antibiot; 2011 Jun; 64(3):179-90. PubMed ID: 21861309
[TBL] [Abstract][Full Text] [Related]
14. Population Pharmacokinetic Modelling of Acetaminophen and Ibuprofen: the Influence of Body Composition, Formulation and Feeding in Healthy Adult Volunteers.
Morse JD; Stanescu I; Atkinson HC; Anderson BJ
Eur J Drug Metab Pharmacokinet; 2022 Jul; 47(4):497-507. PubMed ID: 35366213
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic/pharmacodynamic serum and urine profile of cefditoren following single-dose and multiple twice- and thrice-daily regimens in healthy volunteers: a phase I study.
Sádaba B; Azanza JR; Quetglas EG; Campanero MA; Honorato J; Coronel P; Gimeno M
Rev Esp Quimioter; 2007 Mar; 20(1):51-60. PubMed ID: 17530036
[TBL] [Abstract][Full Text] [Related]
16. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
Zhou H; Mayer PR; Wajdula J; Fatenejad S
J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
[TBL] [Abstract][Full Text] [Related]
17. Effects of sugar ester and hydroxypropyl methylcellulose on the physicochemical stability of amorphous cefditoren pivoxil in aqueous suspension.
Yokoi Y; Yonemochi E; Terada K
Int J Pharm; 2005 Feb; 290(1-2):91-9. PubMed ID: 15664134
[TBL] [Abstract][Full Text] [Related]
18. [A clinical study on cefditoren pivoxil granules in the pediatric field].
Mori A; Meguro H; Terashima I; Fujii R
Jpn J Antibiot; 1993 Jul; 46(7):577-88. PubMed ID: 8371493
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients.
Hennig S; Wainwright CE; Bell SC; Miller H; Friberg LE; Charles BG
Clin Pharmacokinet; 2006; 45(11):1099-114. PubMed ID: 17048974
[TBL] [Abstract][Full Text] [Related]
20. Memantine pharmacotherapy: a naturalistic study using a population pharmacokinetic approach.
Kornhuber J; Kennepohl EM; Bleich S; Wiltfang J; Kraus T; Reulbach U; Meineke I
Clin Pharmacokinet; 2007; 46(7):599-612. PubMed ID: 17596105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
